Methoxetamine

Share on Facebook Share on Twitter Email
Top
Methoxetamine
Systematic (IUPAC) name
(RS)2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone[1]
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 1239943-76-0 YesY
ATC code None
ChemSpider 24721792 YesY
Chemical data
Formula C15H21NO2 
Mol. mass 247.33 g/mol
SMILES eMolecules & PubChem
 YesY (what is this?)  (verify)

Methoxetamine (MXE) or 3-MeO-2-Oxo-PCE is a chemical of the arylcyclohexylamine class which has been sold as a designer drug.[1] It is a derivative of ketamine that also contains structural features of eticyclidine and 3-MeO-PCP. Methoxetamine is thought to behave as a NMDA receptor antagonist and dopamine reuptake inhibitor, though it has not been formally profiled pharmacologically.[2][3] Methoxetamine differs from many other dissociative anesthetics of the arylcyclohexylamine class in that it was designed for grey market distribution.[4] Methoxetamine is a product of rational drug design: its N-ethyl group was chosen to increase potency.[4]

Contents

Physical properties

Pure methoxetamine is a white powder.[5] It has low solubility in isopropanol, 6 mg mL-1 at -10 centigrade.[6]

Emergence

The European Monitoring Centre for Drugs and Drug Addiction, which monitors the internet for new psychoactive substances within the European Union, first identified methoxetamine in November 2010.[1] By July 2011, they had identified 58 websites selling the compound, at a cost of 145–195 euros for 10 grams.[7]

Effects

It is reported to have similar desirable and unwanted effects to ketamine, although some users have reported that the unwanted effects last longer than for ketamine.[8] Little is known about the potential toxicity of methoxetamine, but people have been hospitalized in the US and UK after using it recreationally.[3][9][10] Acute cerebellar toxicity has been documented in three cases of hospital admission due to methoxetamine overdose, lasting for between one and four days after exposure.[10]

Methoxetamine has been marketed as "bladder friendly", referencing the bladder damage associated with chronic ketamine use, but further scientific research is required to determine whether this is the case.[9][11] From the limited information available based on user reports on internet discussion forums, toxicologists have stated it has "potential to be associated with significant acute harm/toxicity if used as a recreational drug."[8]

Legal status

Methoxetamine powder
Theresa May commented in her reply to the ACMD that "the next step in this process is for the ACMD to undertake a full assessment of methoxetamine for consideration for its permanent control under the 1971 Act." She goes on to say that she hopes the ACMD will do this as a part of the review of ketamine, "including its analogues" and that this review will be completed "within the 12 months from the making of the current order".[17]

Media coverage

Mixmag reported in January 2012, that people in the dance music and clubbing community have given methoxetamine the slang name 'roflcoptr'.[20] Vice commented that it was likely that the phrase will only be used by "the same politicians, parents and journalists" who called mephedrone 'meow meow'.[21] After being called mexxy in UK Home Office press releases users and the media adopted the name[22] despite this being an uncommon term before its receiving media attention.[23]

A literature review was published in March 2012 which looked at scientific literature and information on the web. It concluded that "the online availability of information on novel psychoactive drugs, such as methoxetamine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast-growing phenomenon."[24]

See also

References

  1. ^ a b c EMCDDA Annual Report 2010 (Report). European Monitoring Centre for Drugs and Drug Addiction. 2010. http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf. Retrieved 2012-01-23. 
  2. ^ Hays, P. A.; Casale, J. F.; Berrier, A. L. (2012). "The Characterization of 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone (Methoxetamine)" (pdf). Microgram Journal 9 (1): 3–17. http://www.justice.gov/dea/programs/forensicsci/microgram/journal2012/mj9-1_3-17.pdf. 
  3. ^ a b Ward, J.; Rhyee, S.; Plansky, J. (2011). "Methoxetamine: A Novel Ketamine Analog and Growing Health-Care Concern". Clinical Toxicology 49 (9): 874–875. doi:10.3109/15563650.2011.617310. PMID 21981756.  edit
  4. ^ a b Morris, H. (2011-02-11). "Interview with a ketamine chemist: or to be more precise, an arylcyclohexylamine chemist". Vice Magazine. http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php?page=1. Retrieved 2012-01-23. 
  5. ^ "Methoxetamine FRANK". http://www.talktofrank.com/drug/methoxetamine. Retrieved 2012-04-14. 
  6. ^ "The Big & Dandy Methoxetamine Thread: 9th dose - Tolerance Schmolerance". 2012-04-12. http://www.bluelight.ru/vb/threads/618922-The-Big-amp-Dandy-Methoxetamine-Thread-9th-dose-Tolerance-Schmolerance?p=10503786&viewfull=1#post10503786. Retrieved 2012-04-14. 
  7. ^ Online sales of new psychoactive substances/‘legalhighs’: Summary of results from the 2011 multilingual snapshots (Report). European Monitoring Centre for Drugs and Drug Addiction. 2011-11-15. http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf. Retrieved 2012-01-23. 
  8. ^ a b Wood, D. M.; Davies, S.; Calapis, A.; Ramsey, J.; Dargan, P. I. (2011). "Novel Drugs -- Novel Branding". QJM. doi:10.1093/qjmed/hcr191. PMID 21997441.  edit
  9. ^ a b Wood, D. M.; Davies, S.; Puchnarewicz, M.; Johnston, A.; Dargan, P. I. (2011). "Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine". European Journal of Clinical Pharmacology 68 (5): 853–856. doi:10.1007/s00228-011-1199-9. PMID 22205276.  edit
  10. ^ a b Shields, J. E.; Dargan, P. I.; Wood, D. M.; Puchnarewicz, M.; Davies, S.; Waring, W. S. (2012). "Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation". Clinical Toxicology 50 (5): 438–440. doi:10.3109/15563650.2012.683437. PMID 22578175.  edit
  11. ^ Daly, M.; Simonson, P. (November 2011). "Street drug trends survey 2011". Drugscope. http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Publications/StreetDrugsSurvey2011.pdf. Retrieved 2012-01-03. 
  12. ^ McPherson, P. (2012-02-13). "Health alert over drug sold as 'safe ketamine'". The Independent. http://www.independent.co.uk/life-style/health-and-families/health-news/health-alert-over-drug-sold-as-safe-ketamine-6804824.html. Retrieved 2012-02-18. 
  13. ^ http://www.homeoffice.gov.uk/media-centre/news/mexxy
  14. ^ Johnson, Wesley (2012-03-06). "Bid to ban 'safe' drug Methoxetamine after deaths". The Independent. http://www.independent.co.uk/life-style/health-and-families/health-news/bid-to-ban-safe-drug-methoxetamine-after-deaths-7542175.html. Retrieved 2012-05-12. 
  15. ^ "Statement of evidence - methoxetamine" (PDF). UK Home Office. 2012-02-23. http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/statement-methoxetamine. Retrieved 2012-03-29. 
  16. ^ "Methoxetamine". Home Office UK. http://www.homeoffice.gov.uk/drugs/drug-law/temporary-class-drug-orders/methoxetamine/. Retrieved 2012-05-17. 
  17. ^ "Home Secretary's response to the ACMD's advice on methoxetamine". UK Home Office. 2012-03-28. http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/methoxetamine-hsresponse. Retrieved 2012-03-28. 
  18. ^ "Resolution of the Government of the Russian Federation on October 6, 2011 N 822". http://www.rg.ru/2011/10/19/narko-dok.html. Retrieved 2012-02-20.  (Russian)
  19. ^ "Ordinance on the lists of narcotic drugs, psychotropic substances, precursors and auxiliary chemicals". http://www.admin.ch/dokumentation/gesetz/00068/index.html?lang=de&download=NHzLpZeg7t,lnp6I0NTU042l2Z6ln1acy4Zn4Z2qZpnO2Yuq2Z6gpJCDeHx2gWym162epYbg2c_JjKbNoKSn6A--. Retrieved 2012-02-20.  (German)
  20. ^ Beaumont-Thomas, B. (2012-01-18). "Methoxetamine is a new chemical analogue of ketamine. It's legal, it's cheap and it's trippy as hell - but is it safe?". London, UK: Mixmag. p. 60. 
  21. ^ Miller, A. (2011-02-11). "We Interviewed the Inventor of Roflcoptr, the New Drug Britain's Panicking About". Vice Magazine. http://www.vice.com/en_uk/read/we-interviewed-the-man-who-invented-roflecoptr. Retrieved 2011-02-11. 
  22. ^ http://www.guardian.co.uk/society/2012/mar/28/legal-high-drug-methoxetamine-banned
  23. ^ "Methoxetamine information.". 2012-04-13. http://www.roflcoptr.co.uk/. Retrieved 2012-05-12. 
  24. ^ Corazza, O.; Schifano, F.; Simonato, P.; Fergus, S.; Assi, S.; Stair, J.; Corkery, J.; Trincas, G. et al (2012). "Phenomenon of New Drugs on the Internet: The Case of Ketamine Derivative Methoxetamine". Human Psychopharmacology: Clinical and Experimental 27 (2): 145. doi:10.1002/hup.1242. PMID 22389078.  edit

External links



Post a question - any question - to the WikiAnswers community:

Copyrights: